Ibogaine Infusion logo: infinity symbol with iboga leaves and fruitIbogaine Infusion
Atmospheric botanical art in forest green, cream, and gold — clinical sanctuary mood

IV ibogaine infusion — physician-supervised, monitored, honest

True psychoactive intravenous ibogaine in a medical infusion setting: consult, cardiac screening, continuous monitoring, and structured integration afterward.

Physician-supervised IV ibogaine infusion programs discussed on this site are provisionally available in Mexico (not an FDA-approved U.S. clinic treatment). Ibogaine remains Schedule I in the United States and is not FDA-approved for any indication. Availability abroad is not a guarantee of suitability, legality for any individual, or clinical outcome. Cardiac screening and continuous monitoring remain essential. This is educational information, not legal or medical advice.

Start confidential application →

Clarity over clinic marketing language

IV ibogaine infusion (also called intravenous ibogaine) is the psychoactive delivery of ibogaine by intravenous infusion under physician supervision. The patient journey parallels ketamine infusion clinics in journey shape only (consult → cardiac screening → monitored IV infusion → integration) — not legal, evidence, or risk equivalence. Continuous ECG/telemetry is non-negotiable because ibogaine can prolong the QTc interval.

Evidence gap: Most published clinical literature — including Cherian et al., Nature Medicine 2024 — describes oral ibogaine HCl, often with IV magnesium support, not IV ibogaine as the psychoactive dose. Controlled evidence for psychoactive IV ibogaine remains sparse. Ibogaine is U.S. Schedule I and not FDA-approved.

On this site, “infusion” is not a spa label for oral dosing with a saline lock. Support IV ≠ psychoactive IV. Read the definition hub.

Screening-first

Cardiac history, ECG, medications, and go/no-go before any infusion conversation.

True IV psychoactive

Ibogaine itself by intravenous infusion — not oral dosing labeled as “infusion.”

Monitored sanctuary

Physician oversight, continuous telemetry, and a calm clinical setting designed for dignity.

Quiet clinical suite with forest-green walls, cream linens, and soft natural light

A calm suite for serious medicine

Luxury here means dignity and clinical seriousness — not spectacle. Private space, physician oversight, and continuous monitoring for true psychoactive IV ibogaine infusion. Programs discussed on this site are provisionally available in Mexico — not an FDA-approved U.S. clinic pathway.

  • • Continuous cardiac monitoring during the high-risk window
  • • Written clarity on psychoactive route vs support IV
  • • Integration planning after the acute window

Cardiac safety

  • Pre-treatment ECG and medication/electrolyte review
  • Continuous cardiac monitoring during the high-risk window
  • Physician oversight and emergency preparedness
  • Written clarity on psychoactive route and any concurrent support IV

Safety & screening · ECG checklist

How the medical journey works

  1. Consult — history, goals, medications, contraindications
  2. Cardiac & medical screening — ECG, labs as indicated, go/no-go
  3. Monitored IV infusion — psychoactive intravenous ibogaine + telemetry
  4. Integration / aftercare — psychosocial planning after the acute window

Step-by-step: how it works. Cost diligence: cost overview · clinic vetting.

Compare carefully

Homepage FAQ

What is IV ibogaine infusion?

Intravenous delivery of ibogaine as the psychoactive treatment under physician supervision in a medical infusion setting, with cardiac screening, continuous monitoring, and integration afterward.

Are programs available in Mexico?

Physician-supervised IV ibogaine infusion programs discussed on this site are provisionally available in Mexico. That is not the same as FDA-approved care in the United States. Ibogaine remains Schedule I federally and is not FDA-approved. Foreign availability is not legal advice, not a guarantee you will qualify, and not a prediction of benefit or safety. See /safety-and-screening and /blog/is-ibogaine-legal-us (educational only).

Is published research mostly oral?

Yes. Landmark examples include Knuijver et al. (Addiction, 2021; oral HCl, QTc) and Cherian et al. (Nature Medicine, 2024; oral ibogaine + IV magnesium). Controlled IV-psychoactive evidence is sparse.

Is ibogaine FDA-approved?

No. It is not FDA-approved for any indication and is Schedule I in the United States.

Is cardiac screening required?

Yes. Ibogaine can prolong QTc. Screening and continuous monitoring are ethical and clinical non-negotiables for any medical program.

How do I start?

Read safety and how-it-works education, then submit a confidential application at /apply.

Start with safety, then apply confidentially

Screening comes before any treatment conversation — not after a sales pitch. Supervised IV ibogaine infusion inquiry is available provisionally in Mexico; not a U.S. FDA-approved clinic.

Start confidential application